- Early Stage Identificationby Brandon TudorWhy early liver disease detection in U.S. adults is a clinical and financial necessity Liver disease can develop quietly for years. By the time a patient feels sick, the opportunity… Read more: Early Stage Identification
- See LiverRight at AASLD: Booth 2267by Pete CelanoSee our Dave Sires and others there. (approximate size )
- Moderate Drinking and Liver Diseaseby David SiresThe Science Daily article “Even moderate drinking linked to cancer and early death, major study finds” from November 1, 2026 (Source: Columbia University’s Mailman School of Public Health) is worth… Read more: Moderate Drinking and Liver Disease
- Liver Cancer: Key Notes for Womenby Brandon TudorGive a read here, posted at Women’sHealth on 1/28/2026: “Liver cancer can have ‘flu-like symptoms – 9 key signs women should take seriously.” The article’s main message: liver cancer can… Read more: Liver Cancer: Key Notes for Women
- Lean Adults and Fatty Liver Diseaseby Pete CelanoThis 10/26/2026 article in the Hep Newsletter titled “Lean People With Fatty Liver Disease Face Higher Risk of Death” is important. Being thin does not guarantee a healthy liver. The… Read more: Lean Adults and Fatty Liver Disease
- Frailty Index in Cirrhosisby David SiresThis 10/23/2026 titled “Development and internal validation of the Laboratory-based Liver Frailty Index (Lab-LFI)—a prediction model for frailty in patients with cirrhosis” in Liver Transplantation (AASLD) is worth reading. It… Read more: Frailty Index in Cirrhosis
- Rising Awareness in Liverby David SiresFatty liver disease is widespread, often silent, and finally getting more attention worldwide. This 10/23/2026 JAMA news article titled “Steatotic Liver Disease Is Becoming a Higher Priority Worldwide” explains why… Read more: Rising Awareness in Liver
- Genetics and MASLD/MASHby Brandon TudorThe article “Study identifies new genetic factors underlying fat accumulation in the liver” from 10/21/2026 in News Medical has a reveal– Some people inherit a greater tendency to store fat… Read more: Genetics and MASLD/MASH
- Cancer Screening in ALDby David SiresThis article titled “Routine liver cancer screening extends lives for patients with alcohol-associated cirrhosis” on 10/20/2026 from News Medical speaks to liver cirrhosis caused by alchohol use. Regular liver cancer… Read more: Cancer Screening in ALD
- Fatty Liver: 5 Patternsby Pete CelanoFatty liver disease can follow very different paths—and someone’s weight or diabetes status may not reveal how serious their liver risk is. That is the main message of this study… Read more: Fatty Liver: 5 Patterns
- Recompensationby Brandon TudorThe 10/14/2026 article titled “Recompensation may represent a new treatment-related state in cirrhosis” was published by the American Association for the Advancement of Science (AAAS). Recompensation means that someone whose… Read more: Recompensation
- MASLD, Seniors and GLP-1sby David SiresWe just read the article titled “GLP-1-based treatments and long-term clinical outcomes in MASLD amongst older adults: a retrospective cohort study” from the 09/21/2026 edition of Age & Aging. GLP-1… Read more: MASLD, Seniors and GLP-1s
- Liver Health is Heart Healthby Brandon TudorThe main message from the article “Cardiovascular Complications of Chronic Liver Disease” is that liver disease can threaten your heart as well as your liver—and that connection is often overlooked.… Read more: Liver Health is Heart Health
- Providers: How to Refer to LiverRightby Pete CelanoLiver disease access in the USA? Months-out, in person. LiverRight makes it same-week, telemedicine. Refer to our clinic in all 50 states, and we’ll deliver on liver for YOUR patients. … Read more: Providers: How to Refer to LiverRight
- Trouble in the Liverby David SiresIn his October 7, 2026 Forbes article, “The Next Big Health Crisis May Be Hiding in Your Liver,” Dr. Peter Ubel highlights the growing public health threat of metabolic dysfunction–associated… Read more: Trouble in the Liver
- OTC Pain Relievers and Your Liverby Pete CelanoHere’s an important LiverRight patient-education topic, because the intuitive consumer belief—“Tylenol affects the liver, therefore Advil must be safer for liver patients”—misses the much more important NSAID risk in advanced… Read more: OTC Pain Relievers and Your Liver
- Why LI-RADSby Brandon TudorThe article entitled “Liver Imaging System LI-RADS Emerges as a Powerful Prognostic Biomarker in Liver Cancer” from Bioengineer dated 10/03/2026 discusses a major shift in how doctors treat liver cancer… Read more: Why LI-RADS
- Donor Organs at the Limitby David SiresThe Bioengineer.com article “Older Donors, Warmer Organs: How the US Organ Recovery System Is Being Pushed to Its Limits” summarizes a 2026 review by Michigan Medicine transplant surgeons Christina Fleischer… Read more: Donor Organs at the Limit
- Hello, Liver Awareness Monthby Pete Celano
- Liver-Cancer Surveillanceby David SiresSee this 2026 Journal of Hepatology review titled “Surveillance of patients at risk of liver cancer: Expert opinions.” It asks an important question: Does routinely screening people at high risk… Read more: Liver-Cancer Surveillance
- Liver and Cardiometabolicby Brandon TudorThe article from NCQA on 09/25/2026 titled “Why Liver Health Belongs in the Cardiometabolic Conversation” argues that liver health belongs in routine cardiometabolic care. Obesity, type 2 diabetes, high blood… Read more: Liver and Cardiometabolic
- Multi-Cancer Early Detection Blood Testingby David SiresThe OHSU article titled “PATHFINDER 2 findings advance multi-cancer early detection blood testing” illuminates a blood test that helps increase cancer detection 6.5-fold, and identifies many cancers lacking routine screening… Read more: Multi-Cancer Early Detection Blood Testing
- More Transplants Eligibilityby Brandon TudorBeing turned down for a liver transplant may no longer be the final answer. Penn Medicine is expanding eligibility for selected patients, including some with recent alcohol use, certain cancers,… Read more: More Transplants Eligibility
- MASLD Cirrhosis Before Age 50by Brandon TudorA large biopsy-confirmed study found that fatty liver–related cirrhosis is not limited to older adults. About one in four MASLD cirrhosis cases occurred before age 50. The key article is… Read more: MASLD Cirrhosis Before Age 50
- Early-Onset Fatty Liver Disease Studyby Pete CelanoConsider “Study Finds Why Young Adults May Develop Early Fatty Liver Disease (Genetics and type 2 diabetes can help identify individuals at risk for advanced liver disease before age 50,… Read more: Early-Onset Fatty Liver Disease Study
- Screening in Liver Cancerby David SiresThe article titled “For Liver Cancer, Screening, Not Treatment, Poses the Biggest Challenge” from US Medicine on 09/10/2026 indicates that liver cancer treatment has improved significantly, but the larger challenge… Read more: Screening in Liver Cancer
- HCV and Corrections Careby Pete CelanoThe Health Affairs article titled “The National Hepatitis C Plan Needs A Correctional-Care Standard” argues that the United States cannot eliminate hepatitis C without establishing a consistent national standard for… Read more: HCV and Corrections Care
- LiverRight and AEGLE MEDICAL Partnerby David SiresLiverRight and AEGLE MEDICAL Solutions, LLC Form Strategic Partnership to Expand Access to Liver Disease Detection, Diagnosis and Care Collaboration combines AEGLE MEDICAL’s liver assessment technology solutions, nationwide implementation and… Read more: LiverRight and AEGLE MEDICAL Partner
- AI and Digital Pathology in Liver Diseaseby David SiresThis new Lancet Digital Health 09/04/2026 paper titled “Digital pathology, image analysis, and artificial intelligence in liver disease” is a broad review of how digital pathology and AI could improve… Read more: AI and Digital Pathology in Liver Disease